Molecular Partners AG Share Price
NASDAQ: MOLN$0.00
+0.00 (0.00%) Molecular Partners AG Stock Performance
Molecular Partners AG Share Price Chart
$0.00$0.00
L
H
Molecular Partners AG Annual Profit & Loss
All figures in USD
About Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.
Molecular Partners AG Historical Returns
| Month | Open | Close | Change % |
|---|